News

Tariffs, funding cuts threaten the ecosystem of companies and research institutes that have made the Commonwealth a biotech ...
A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration later this month.
CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine for patients with advanced ...
The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...
The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...
Writing for SBM these days is a bit like being in one of those cash grab machines, though instead of money flying over the ...
A new COVID variant - NB 1.8.1 - is creeping across California; here are the symptoms to watch for, and vaccinations you'll ...
An afternoon snooze might seem appealing to middle-aged folks and seniors, but these naps could carry a high cost.
Alnylam Pharmaceuticals Inc. won’t get another chance at its patent infringement suit against Moderna Inc. over its mRNA Covid-19 vaccine, a federal appeals court ruled Wednesday.
A new COVID variant - NB 1.8.1 - is creeping across the country; here are the symptoms to watch for, and vaccinations you'll need to take.
In a precedential decision issued June 4, 2025, the U.S. Court of Appeals for the Federal Circuit (CAFC) affirmed a district court's finding of noninfringement in favor of Moderna, Inc. in its ongoing ...
In a crucial development, the FDA has approved Moderna's new COVID-19 vaccine designed specifically for high-risk Americans.